Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity.
Qiao Y, Qiu Y, Ding J, Luo N, Wang H, Ling X, Sun J, Wu Z, Wang Y, Liu Y, Guo F, Sun T, Shen W, Zhang M, Wu D, Chen B, Xu W, Wang X.
Qiao Y, et al. Among authors: wang h, wang x, wang y.
Nat Commun. 2021 Nov 4;12(1):6360. doi: 10.1038/s41467-021-26645-6.
Nat Commun. 2021.
PMID: 34737267
Free PMC article.